110 ALLEN ROAD, BASKING RIDGE, NJ
Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement, Investor Presentation
Material disclosure
Lisata Therapeutics Enters Amendment to Merger Agreement with Kuva Labs
Other Events
Q2
Q1
Amended Annual Report
FY 2025
Q3
FY 2024
Notice of Exempt Offering of Securities
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Third Party
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Correspondence